Publications found:
61,464
Sort by:
Pressure Ulcers R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF PRESSURE ULCERS PIPELINE REPORT INCLUDES Panorama of Pressure Ulcers pipeline markets including statistics on therapeutic drugs and companies involved Pressure Ulcers Pipeline candidates across various development ...
August 2018
30 pages
Primary Biliary Cirrhosis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF PRIMARY BILIARY CIRRHOSIS PIPELINE REPORT INCLUDES Panorama of Primary Biliary Cirrhosis pipeline markets including statistics on therapeutic drugs and companies involved Primary Biliary Cirrhosis Pipeline candidates across various development ...
August 2018
90 pages
Primary Hyperoxaluria R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF PRIMARY HYPEROXALURIA PIPELINE REPORT INCLUDES Panorama of Primary Hyperoxaluria pipeline markets including statistics on therapeutic drugs and companies involved Primary Hyperoxaluria Pipeline candidates across various development ...
August 2018
40 pages
Primary Immune Deficiency R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF PRIMARY IMMUNE DEFICIENCY PIPELINE REPORT INCLUDES Panorama of Primary Immune Deficiency pipeline markets including statistics on therapeutic drugs and companies involved Primary Immune Deficiency Pipeline candidates across various development ...
August 2018
70 pages
Primary Progressive Multiple Sclerosis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS PIPELINE REPORT INCLUDES Panorama of Primary Progressive Multiple Sclerosis pipeline markets including statistics on therapeutic drugs and companies involved Primary Progressive Multiple Sclerosis Pipeline candidates across ...
August 2018
80 pages
Primary Sclerosing Cholangitis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF PRIMARY SCLEROSING CHOLANGITIS PIPELINE REPORT INCLUDES Panorama of Primary Sclerosing Cholangitis pipeline markets including statistics on therapeutic drugs and companies involved Primary Sclerosing Cholangitis Pipeline candidates across various development ...
August 2018
80 pages
Progressive Multifocal Leukoencephalopathy R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY PIPELINE REPORT INCLUDES Panorama of Progressive Multifocal Leukoencephalopathy pipeline markets including statistics on therapeutic drugs and companies involved Progressive Multifocal Leukoencephalopathy Pipeline candidates across various ...
August 2018
20 pages
Progressive Relapsing Multiple Sclerosis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF PROGRESSIVE RELAPSING MULTIPLE SCLEROSIS PIPELINE REPORT INCLUDES Panorama of Progressive Relapsing Multiple Sclerosis pipeline markets including statistics on therapeutic drugs and companies involved Progressive Relapsing Multiple Sclerosis Pipeline candidates across ...
August 2018
30 pages
Progressive Supranuclear Palsy R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF PROGRESSIVE SUPRANUCLEAR PALSY PIPELINE REPORT INCLUDES Panorama of Progressive Supranuclear Palsy pipeline markets including statistics on therapeutic drugs and companies involved Progressive Supranuclear Palsy Pipeline candidates across various development ...
August 2018
60 pages
Proliferative Diabetic Retinopathy R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF PROLIFERATIVE DIABETIC RETINOPATHY PIPELINE REPORT INCLUDES Panorama of Proliferative Diabetic Retinopathy pipeline markets including statistics on therapeutic drugs and companies involved Proliferative Diabetic Retinopathy Pipeline candidates across various development ...
August 2018
40 pages
Proliferative Vitreoretinopathy (PVR) R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF PROLIFERATIVE VITREORETINOPATHY (PVR) PIPELINE REPORT INCLUDES Panorama of Proliferative Vitreoretinopathy (PVR) pipeline markets including statistics on therapeutic drugs and companies involved Proliferative Vitreoretinopathy (PVR) Pipeline candidates across various development ...
August 2018
30 pages
Prosthetic joint infections R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF PROSTHETIC JOINT INFECTIONS PIPELINE REPORT INCLUDES Panorama of Prosthetic joint infections pipeline markets including statistics on therapeutic drugs and companies involved Prosthetic joint infections Pipeline candidates across various development ...
August 2018
40 pages
Pruritus R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF PRURITUS PIPELINE REPORT INCLUDES Panorama of Pruritus pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
110 pages
Pseudomonas aeruginosa Pneumonia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF PSEUDOMONAS AERUGINOSA PNEUMONIA PIPELINE REPORT INCLUDES Panorama of Pseudomonas aeruginosa Pneumonia pipeline markets including statistics on therapeutic drugs and companies involved Pseudomonas aeruginosa Pneumonia Pipeline candidates across various development ...
August 2018
30 pages
Psoriatic Arthritis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF PSORIATIC ARTHRITIS PIPELINE REPORT INCLUDES Panorama of Psoriatic Arthritis pipeline markets including statistics on therapeutic drugs and companies involved Psoriatic Arthritis Pipeline candidates across various development ...
August 2018
190 pages
Psychosis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF PSYCHOSIS PIPELINE REPORT INCLUDES Panorama of Psychosis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
60 pages
Pulmonary Embolism R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF PULMONARY EMBOLISM PIPELINE REPORT INCLUDES Panorama of Pulmonary Embolism pipeline markets including statistics on therapeutic drugs and companies involved Pulmonary Embolism Pipeline candidates across various development ...
August 2018
30 pages
Pyelonephritis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF PYELONEPHRITIS PIPELINE REPORT INCLUDES Panorama of Pyelonephritis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
80 pages
Q Fever R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... VPA Research with comprehensive information of Q Fever pipeline products. The Q Fever pipeline guide presents complete overview of drugs currently ... and ready to use format. SCOPE OF Q FEVER PIPELINE REPORT INCLUDES Panorama of Q Fever pipeline markets including statistics on therapeutic drugs and companies ...
August 2018
30 pages
Rabies R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF RABIES PIPELINE REPORT INCLUDES Panorama of Rabies pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
60 pages
Radiation Injury R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF RADIATION INJURY PIPELINE REPORT INCLUDES Panorama of Radiation Injury pipeline markets including statistics on therapeutic drugs and companies involved Radiation Injury Pipeline candidates across various development ...
August 2018
40 pages
Radiodermatitis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF RADIODERMATITIS PIPELINE REPORT INCLUDES Panorama of Radiodermatitis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
30 pages
Ragweed Allergy R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF RAGWEED ALLERGY PIPELINE REPORT INCLUDES Panorama of Ragweed Allergy pipeline markets including statistics on therapeutic drugs and companies involved Ragweed Allergy Pipeline candidates across various development ...
August 2018
30 pages
Ragweed Pollen Allergy R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF RAGWEED POLLEN ALLERGY PIPELINE REPORT INCLUDES Panorama of Ragweed Pollen Allergy pipeline markets including statistics on therapeutic drugs and companies involved Ragweed Pollen Allergy Pipeline candidates across various development ...
August 2018
30 pages
Raynauds Disease R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF RAYNAUDS DISEASE PIPELINE REPORT INCLUDES Panorama of Raynauds Disease pipeline markets including statistics on therapeutic drugs and companies involved Raynauds Disease Pipeline candidates across various development ...
August 2018
40 pages
Rectal Cancer R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF RECTAL CANCER PIPELINE REPORT INCLUDES Panorama of Rectal Cancer pipeline markets including statistics on therapeutic drugs and companies involved Rectal Cancer Pipeline candidates across various development ...
August 2018
90 pages
Recurrent Malignant Glioma R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF RECURRENT MALIGNANT GLIOMA PIPELINE REPORT INCLUDES Panorama of Recurrent Malignant Glioma pipeline markets including statistics on therapeutic drugs and companies involved Recurrent Malignant Glioma Pipeline candidates across various development ...
August 2018
40 pages
Reflux Esophagitis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF REFLUX ESOPHAGITIS PIPELINE REPORT INCLUDES Panorama of Reflux Esophagitis pipeline markets including statistics on therapeutic drugs and companies involved Reflux Esophagitis Pipeline candidates across various development ...
August 2018
60 pages
Refractory Chronic Lymphocytic Leukemia (CLL) R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PIPELINE REPORT INCLUDES Panorama of Refractory Chronic Lymphocytic Leukemia (CLL) pipeline markets including statistics on therapeutic drugs and companies involved Refractory Chronic Lymphocytic Leukemia (CLL) Pipeline candidates across ...
August 2018
210 pages
Relapsed Chronic Lymphocytic Leukemia (CLL) R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PIPELINE REPORT INCLUDES Panorama of Relapsed Chronic Lymphocytic Leukemia (CLL) pipeline markets including statistics on therapeutic drugs and companies involved Relapsed Chronic Lymphocytic Leukemia (CLL) Pipeline candidates across ...
August 2018
240 pages
Relapsing Remitting Multiple Sclerosis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF RELAPSING REMITTING MULTIPLE SCLEROSIS PIPELINE REPORT INCLUDES Panorama of Relapsing Remitting Multiple Sclerosis pipeline markets including statistics on therapeutic drugs and companies involved Relapsing Remitting Multiple Sclerosis Pipeline candidates across ...
August 2018
150 pages
Renal Anemia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF RENAL ANEMIA PIPELINE REPORT INCLUDES Panorama of Renal Anemia pipeline markets including statistics on therapeutic drugs and companies involved Renal Anemia Pipeline candidates across various development ...
August 2018
90 pages
Resistant Hypertension R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF RESISTANT HYPERTENSION PIPELINE REPORT INCLUDES Panorama of Resistant Hypertension pipeline markets including statistics on therapeutic drugs and companies involved Resistant Hypertension Pipeline candidates across various development ...
August 2018
30 pages
Resistant Pseudomonas aeruginosa Infection R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF RESISTANT PSEUDOMONAS AERUGINOSA INFECTION PIPELINE REPORT INCLUDES Panorama of Resistant Pseudomonas aeruginosa Infection pipeline markets including statistics on therapeutic drugs and companies involved Resistant Pseudomonas aeruginosa Infection Pipeline candidates across ...
August 2018
40 pages
Restenosis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF RESTENOSIS PIPELINE REPORT INCLUDES Panorama of Restenosis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
40 pages
Restless Legs Syndrome R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF RESTLESS LEGS SYNDROME PIPELINE REPORT INCLUDES Panorama of Restless Legs Syndrome pipeline markets including statistics on therapeutic drugs and companies involved Restless Legs Syndrome Pipeline candidates across various development ...
August 2018
40 pages
Retinal Vein Occlusion R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF RETINAL VEIN OCCLUSION PIPELINE REPORT INCLUDES Panorama of Retinal Vein Occlusion pipeline markets including statistics on therapeutic drugs and companies involved Retinal Vein Occlusion Pipeline candidates across various development ...
August 2018
80 pages
Retinitis Pigmentosa R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF RETINITIS PIGMENTOSA PIPELINE REPORT INCLUDES Panorama of Retinitis Pigmentosa pipeline markets including statistics on therapeutic drugs and companies involved Retinitis Pigmentosa Pipeline candidates across various development ...
August 2018
150 pages
Retinoblastoma R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF RETINOBLASTOMA PIPELINE REPORT INCLUDES Panorama of Retinoblastoma pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
40 pages
Retinopathy Of Prematurity (RoP) R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF RETINOPATHY OF PREMATURITY (ROP) PIPELINE REPORT INCLUDES Panorama of Retinopathy Of Prematurity (RoP) pipeline markets including statistics on therapeutic drugs and companies involved Retinopathy Of Prematurity (RoP) Pipeline candidates across ...
August 2018
30 pages
Rett Syndrome R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF RETT SYNDROME PIPELINE REPORT INCLUDES Panorama of Rett Syndrome pipeline markets including statistics on therapeutic drugs and companies involved Rett Syndrome Pipeline candidates across various development ...
August 2018
90 pages
Rhabdomyosarcoma R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF RHABDOMYOSARCOMA PIPELINE REPORT INCLUDES Panorama of Rhabdomyosarcoma pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
210 pages
Rhino Conjunctivitis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF RHINO CONJUNCTIVITIS PIPELINE REPORT INCLUDES Panorama of Rhino Conjunctivitis pipeline markets including statistics on therapeutic drugs and companies involved Rhino Conjunctivitis Pipeline candidates across various development ...
August 2018
60 pages
Rhinovirus Infections R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF RHINOVIRUS INFECTIONS PIPELINE REPORT INCLUDES Panorama of Rhinovirus Infections pipeline markets including statistics on therapeutic drugs and companies involved Rhinovirus Infections Pipeline candidates across various development ...
August 2018
30 pages
Rosacea R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF ROSACEA PIPELINE REPORT INCLUDES Panorama of Rosacea pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
50 pages
Rotavirus Infections R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF ROTAVIRUS INFECTIONS PIPELINE REPORT INCLUDES Panorama of Rotavirus Infections pipeline markets including statistics on therapeutic drugs and companies involved Rotavirus Infections Pipeline candidates across various development ...
August 2018
40 pages
Rubella (German Measles) R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF RUBELLA (GERMAN MEASLES) PIPELINE REPORT INCLUDES Panorama of Rubella (German Measles) pipeline markets including statistics on therapeutic drugs and companies involved Rubella (German Measles) Pipeline candidates across various development ...
August 2018
30 pages
Salivary Gland Cancer R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF SALIVARY GLAND CANCER PIPELINE REPORT INCLUDES Panorama of Salivary Gland Cancer pipeline markets including statistics on therapeutic drugs and companies involved Salivary Gland Cancer Pipeline candidates across various development ...
August 2018
80 pages
Sandhoff Disease R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... with comprehensive information of Sandhoff Disease pipeline products. The Sandhoff Disease pipeline guide presents complete overview ... SANDHOFF DISEASE PIPELINE REPORT INCLUDES Panorama of Sandhoff Disease pipeline markets including statistics on therapeutic drugs and companies involved Sandhoff Disease Pipeline ...
August 2018
20 pages
Sarcopenia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF SARCOPENIA PIPELINE REPORT INCLUDES Panorama of Sarcopenia pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
50 pages
